Registration
Registration in now open
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Virtual Meeting
Benefits of these targeted agents are not limited to tumours with germline BRCA1/2 mutations, but many questions remain to be answered
Findings from the NRG Oncology/GOG Study 279
17 Apr 2024
Chair: Benedikt Westphalen
Co-Chair: George Pentheroudakis
Speakers: Claudia Cardone, Vivek Subbiah, Sewanti Limaye
ESMO thanks the following endorsing societies who have already confirmed their support to the ESMO Gastrointestinal Cancers Congress 2024
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.